Varicella zoster virus infection during chemotherapy in solid cancer patients

Oncology

Volumn 82, Issue 2, 2012, Pages 126-130

  Kim, Seung Tae ^a   Park, Kyong Hwa ^a   Oh, Sang Cheul ^a   Seo, Jae Hong ^a   Shin, Sang Won ^a   Kim, Jun Suk ^a   Kim, Yeul Hong ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Chemotherapy; Solid cancer; Varicella zoster virus

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; COMORBIDITY; FEMALE; HERPES ZOSTER; HUMAN; LEUKOCYTE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROPHYLAXIS; SOLID TUMOR; THROMBOCYTE; TREATMENT RESPONSE; VARICELLA ZOSTER VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; FEMALE; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES;

EID: 84862801171     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000334739     Document Type: Article

References (18)

1. Arvin AM: Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2000; 6: 219-230.
2. Han CS, Miller W, Haake R, Weisdorf D: Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 1994; 13: 277-283. (Pubitemid 24065953)
3. Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM: Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 25: 167-172. (Pubitemid 30087986)
4. Wacker P, Hartmann O, Benhamou E, Salloum E, Lemerle J: Varicella-zoster virus infections after autologous bone marrow transplantation in children. Bone Marrow Transplant 1989; 4: 191-194. (Pubitemid 19089749)
5. Onozawa M, Hashino S, Takahata M, Fujisawa F, Kawamura T, Nakagawa M, Kahata K, Kondo T, Ota S, Tanaka J, Imamura M, Asaka M: Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients. J Clin Microbiol 2006; 44: 4441-4443. (Pubitemid 44937077)
6. Sawyer MH, Chamberlin CJ, Wu YN, Aintablian N, Wallace MR: Detection of varicella-zoster virus DNA in air samples from hospital rooms. J Infect Dis 1994; 169: 91-94.
7. Gnann JW Jr, Whitley RJ: Clinical practice. Herpes zoster. N Engl J Med 2002; 347: 340-346.
8. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ: Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635-645. (Pubitemid 30118417)
9. Straus SE, Ostrove JM, Inchauspe G, Felser JM, Freifeld A, Croen KD, Sawyer MH: NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108: 221-237. (Pubitemid 18081198)
10. Johnson RW: The future of predictors, prevention, and therapy in postherpetic neuralgia. Neurology 1995; 45:S70-S72. (Pubitemid 26163693)
11. Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J, Snydman DR: Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000; 6: 44-49.
12. Kato H, Yamamoto K, Matsuo K, Oki Y, Taji H, Kuwatsuka Y, Seto M, Kagami Y, Morishima Y: Clinical impact and predisposing factors of delayed-onset neutropenia after autologous hematopoietic stem-cell transplantation for B-cell non-Hodgkin lymphoma: association with an incremental risk of infectious events. Ann Oncol 2010; 21: 1699-1705.
13. Kim DH, Messner H, Minden M, Gupta V, Kuruvilla J, Wright J, Lipton J: Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders. Transpl Infect Dis 2008; 10: 90-98. (Pubitemid 351393079)
14. Sandherr M, Einsele H, Hebart H, Kahl C, Kern W, Kiehl M, Massenkeil G, Penack O, Schiel X, Schuettrumpf S, Ullmann AJ, Cornely OA: Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Ann Oncol 2006; 17: 1051-1059. (Pubitemid 43985238)
15. Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, Kaneda M, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Masauji N, Matsunaga T, Mori A, Mukai M, Nishio M, Noto S, Ota S, Sakai H, Suzuki N, Takahashi T, Tanaka J, Torimoto Y, Yoshida M, Fukuhara T: Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Biol Blood Marrow Transplant 2009; 15: 724-729.
16. Leporrier M, Chevret S, Cazin B, Boudjerra N, Feugier P, Desablens B, Rapp MJ, Jaubert J, Autrand C, Divine M, Dreyfus B, Maloum K, Travade P, Dighiero G, Binet JL, Chastang C: Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood 2001; 98: 2319-2325.
17. Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA: Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1750-1757.
18. Pergam SA, Limaye AP: Varicella zoster virus (VZV) in solid organ transplant recipients. Am J Transplant 2009; 9(suppl 4):S108-S115.